Literature DB >> 36209312

Iontophoresis application for drug delivery in high resistivity membranes: nails and teeth.

Jayanaraian F Martins Andrade1, Thamires da Cunha Miranda1, Marcílio Cunha-Filho1, Stephânia Fleury Taveira2, Guilherme M Gelfuso3, Taís Gratieri4.   

Abstract

Iontophoresis has been vastly explored to improve drug permeation, mainly for transdermal delivery. Despite the skin's electrical resistance and barrier properties, it has a relatively high aqueous content and is permeable to many drugs. In contrast, nails and teeth are accessible structures for target drug delivery but possess low water content compared to the skin and impose significant barriers to drug permeation. Common diseases of these sites, such as nail onychomycosis and endodontic microbial infections that reach inaccessible regions for mechanical removal, often depend on time-consuming and ineffective treatments relying on drug's passive permeation. Iontophoresis application in nail and teeth structures may be a safe and effective way to improve drug transport across the nail and drug distribution through dental structures, making treatments more effective and comfortable for patients. Here, we provide an overview of iontophoresis applications in these "hard tissues," considering specificities such as their high electrical resistivity. Iontophoresis presents a promising option to enhance drug permeation through the nail and dental tissues, and further developments in these areas could lead to widespread clinical use.
© 2022. Controlled Release Society.

Entities:  

Keywords:  Dentin; Enamel; High resistivity membranes; Iontophoresis; Nails

Year:  2022        PMID: 36209312     DOI: 10.1007/s13346-022-01244-0

Source DB:  PubMed          Journal:  Drug Deliv Transl Res        ISSN: 2190-393X            Impact factor:   5.671


  78 in total

Review 1.  Iontophoretic drug delivery.

Authors:  Yogeshvar N Kalia; Aarti Naik; James Garrison; Richard H Guy
Journal:  Adv Drug Deliv Rev       Date:  2004-03-27       Impact factor: 15.470

2.  Effect of charge and molecular weight on transdermal peptide delivery by iontophoresis.

Authors:  Nada Abla; Aarti Naik; Richard H Guy; Yogeshvar N Kalia
Journal:  Pharm Res       Date:  2005-09-26       Impact factor: 4.200

3.  Topical iontophoresis of valaciclovir hydrochloride improves cutaneous aciclovir delivery.

Authors:  Nada Abla; Aarti Naik; Richard H Guy; Yogeshvar N Kalia
Journal:  Pharm Res       Date:  2006-08       Impact factor: 4.200

4.  Cutaneous iontophoresis of μ-conotoxin CnIIIC-A potent NaV1.4 antagonist with analgesic, anaesthetic and myorelaxant properties.

Authors:  Sergio Del Río-Sancho; Cecile Cros; Bethsabée Coutaz; Muriel Cuendet; Yogeshvar N Kalia
Journal:  Int J Pharm       Date:  2016-12-26       Impact factor: 5.875

5.  Noninvasive transdermal iontophoretic delivery of biologically active human basic fibroblast growth factor.

Authors:  S Dubey; R Perozzo; L Scapozza; Y N Kalia
Journal:  Mol Pharm       Date:  2011-07-05       Impact factor: 4.939

6.  Electrically-assisted delivery of an anionic protein across intact skin: cathodal iontophoresis of biologically active ribonuclease T1.

Authors:  S Dubey; Y N Kalia
Journal:  J Control Release       Date:  2011-03-21       Impact factor: 9.776

7.  Non-invasive targeted iontophoretic delivery of cetuximab to skin.

Authors:  Maria Lapteva; Marwa A Sallam; Alexandre Goyon; Davy Guillarme; Jean-Luc Veuthey; Yogeshvar N Kalia
Journal:  Expert Opin Drug Deliv       Date:  2020-02-27       Impact factor: 6.648

8.  Transdermal delivery of cytochrome C--A 12.4 kDa protein--across intact skin by constant-current iontophoresis.

Authors:  J Cázares-Delgadillo; A Naik; A Ganem-Rondero; D Quintanar-Guerrero; Y N Kalia
Journal:  Pharm Res       Date:  2007-04-25       Impact factor: 4.200

9.  Simultaneous controlled iontophoretic delivery of pramipexole and rasagiline in vitro and in vivo: Transdermal polypharmacy to treat Parkinson's disease.

Authors:  Dhaval R Kalaria; Mayank Singhal; Vandana Patravale; Virginia Merino; Yogeshvar N Kalia
Journal:  Eur J Pharm Biopharm       Date:  2018-02-22       Impact factor: 5.571

10.  Current profile controlled transdermal delivery of pramipexole from an iontophoretic patch system in vitro and in vivo.

Authors:  Mayank Singhal; César Serna; Virginia Merino; Yogeshvar N Kalia
Journal:  Eur J Pharm Biopharm       Date:  2021-06-25       Impact factor: 5.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.